Actavis obtains final approval from FDA for generic SubutexhealthmedicinetFebruary 21, 2015news / no comments Actavis plc Related posts: HMN 2025: How FDA grants accelerated approval for first treatment for Barth syndrome Previous Post Tandem Diabetes Care announces release of t:simulator App Next Post I Spent a Week Giving My Husband a Lot of Compliments—Here’s What Happened